ArticleBMJ global health2026
Strengthening equitable research capacity in response to infectious diseases of poverty.
Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The inequitable global distribution of resources for research parallels the unequal global distribution of morbidity and mortality due to infectious diseases. Significant gaps in research capacity prevail, and equitable and accessible opportunities for research remain a priority. We argue for the democratisation of research: without equitable participation in, and ownership of, research, by those who are implementing the research or are part of the communities being researched, contextualised research needs and health system bottlenecks will remain unresolved. This perpetuates an inequitable power balance related to research and innovation. Equitable research capacity is fundamental to tackling global health challenges and reducing health inequity. We emphasise the evolution from externally driven, high-income-centric models of research capacity strengthening towards inclusive, context-sensitive approaches that prioritise local ownership, diversity and sustainability. A paradigm shift from 'imposing technical support' to 'fostering ownership of knowledge' has catalysed new models of engagement, such as implementation research capacity among health professionals and communities, and regionally anchored postgraduate training. Institutionalised, inclusive research can align with national priorities and yield measurable improvements in health outcomes. However, persistent inequities rooted in gender, geography and institutional hierarchies continue to constrain participation and impact. Addressing these requires deliberate strategies to democratise access, diversify partnerships and support under-represented institutions and individuals. Allowing dynamic roles in long-term partnerships and regional networks on a continuum between academic partners and capacity-strengthening recipients can support mitigation of intersectional inequities and lead to capacity strengthening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.